Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laddcap Value Partners is a private investment partnership based in New York City, managed by Robert Ladd. The firm is a significant stakeholder in the biotechnology industry, most notably through its long-standing and substantial investment in MannKind Corporation. Robert Ladd, the managing member of Laddcap, has served as the Chief Executive Officer of MannKind since 2017, creating a strong strategic link between the investment firm and the biopharmaceutical company. Laddcap typically engages in value-oriented investing, focusing on companies with significant underlying assets or specialized technologies. The firm operates as a hedge fund, utilizing fundamental analysis to identify undervalued opportunities across various sectors, with a heavy concentration in life sciences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laddcap Value Partners.